Alpha Teknova, Inc.

NasdaqGM:TKNO Stock Report

Market Cap: US$431.8m

Alpha Teknova Past Earnings Performance

Past criteria checks 0/6

Alpha Teknova's earnings have been declining at an average annual rate of -45.5%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.2% per year.

Key information

-45.5%

Earnings growth rate

-28.2%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate5.2%
Return on equity-36.3%
Net Margin-87.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 42%

Oct 15
Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 42%

Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 27
Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%

Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%

Apr 24
Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%

Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?

Jan 22
Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?

Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates

Aug 14
Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates

Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper

Apr 17
Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

May 14
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

Revenue & Expenses Breakdown

How Alpha Teknova makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:TKNO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2436-32313
30 Jun 2435-34324
31 Mar 2437-36345
31 Dec 2337-37356
30 Sep 2337-39356
30 Jun 2339-52367
31 Mar 2339-51387
31 Dec 2241-47378
30 Sep 2244-38367
30 Jun 2242-19337
31 Mar 2239-15286
31 Dec 2137-10244
30 Sep 2137-6203
30 Jun 2137-3162
31 Mar 21340132
31 Dec 20311102
31 Dec 1921-171

Quality Earnings: TKNO is currently unprofitable.

Growing Profit Margin: TKNO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TKNO is unprofitable, and losses have increased over the past 5 years at a rate of 45.5% per year.

Accelerating Growth: Unable to compare TKNO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TKNO is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).


Return on Equity

High ROE: TKNO has a negative Return on Equity (-36.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies